Cellebrite DI (CLBT) Stock Forecast & Price Target

Compare

497 Followers

See the Price Targets and Ratings of:

All Analysts

Top Analysts

Premium

CLBT Analyst Ratings

Moderate Buy

6 Buy

0 Hold

1 Sell

Based on 7 analysts giving stock ratings to

Cellebrite

in the past 3 months

TipRanks enables you to focus on the analyst rating consensus of all analysts or only the top performers in the past 3 months

CLBT Stock 12 Month Forecast

Average Price Target

$24.20

▲(28.59% Upside)

Based on 7 Wall Street analysts offering 12 month price targets for Cellebrite DI in the last 3 months. The average price target is $24.20 with a high forecast of $25.00 and a low forecast of $23.00. The average price target represents a 28.59% change from the last price of $18.82.

{"navigator":{"disabled":true},"exporting":{"enabled":false},"title":{"text":null},"chart":{"height":200,"style":{"fontFamily":"Roboto Flex, -apple-system, BlinkMacSystemFont, Segoe UI, Roboto, Helvetica, Arial, sans-serif, Apple Color Emoji, Segoe UI Emoji, Segoe UI Symbol","fontWeight":"400","color":"#5d5d5e"},"spacingTop":30,"spacingRight":60,"events":null},"yAxis":{"labels":{"style":{"color":"inherit"},"distance":6,"x":-6,"y":-6,"zIndex":1,"map_label_formatter":{"12":"$12","19":"$19","26":"$26","15.5":"$15.5","22.5":"$22.5"}},"plotLines":[{"color":"rgba(0,0,0,0)","value":25,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":-10,"text":"<div  class=\"positionrelative hoverZ3 triangleleft-bottom flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#199ca5\">High </span>\n\n  <span style=\"color:#199ca5\">$25.00</span>\n  </div></div>","useHTML":true}},{"color":"rgba(0,0,0,0)","value":24.2,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":0,"text":"<div  class=\"positionrelative hoverZ3 triangleleft flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#828080\">Average </span>\n\n  <span style=\"color:#828080\">$24.20</span>\n  </div></div>","useHTML":true}},{"color":"rgba(0,0,0,0)","value":23,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":10,"text":"<div  class=\"positionrelative hoverZ3 triangleleft-top flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#912767\">Low </span>\n\n  <span style=\"color:#912767\">$23.00</span>\n  </div></div>","useHTML":true}}],"tickPositions":[12,15.5,19,22.5,26],"lineColor":"#dddddd","gridLineWidth":1,"gridLineColor":"#dddddd","lineWidth":1,"title":{"text":""}},"plotOptions":{"series":{"states":{"inactive":{"opacity":1}}},"line":{"animation":{"duration":0},"dataLabels":{"allowOverlap":true},"borderWidth":1,"marker":{"enabled":true,"fillColor":"#FFFFFF","radius":3,"lineWidth":2,"symbol":"circle","lineColor":"#828080"}}},"xAxis":{"labels":{"style":{"color":"inherit"},"rotation":0,"map_label_formatter":{"3":"Mar<br/>2025","6":"Jun<br/>2025","9":"Sep<br/>2025","12":"Dec<br/>2025","25":"Dec<br/>2026"}},"tickPositions":[3,6,9,12,25],"plotLines":[{"color":"#dddddd","width":1,"value":12},{"color":"#dddddd","width":1,"value":12}],"lineWidth":0,"gridLineWidth":1,"gridLineColor":"#dddddd","tickLength":0},"legend":{"symbolRadius":0,"symbolPadding":4,"symbolHeight":14,"borderWidth":0,"symbolWidth":14,"align":"left","verticalAlign":"bottom","enabled":false},"tooltip":{"backgroundColor":"rgba(0,0,0,0)","useHTML":true,"borderWidth":0,"borderColor":"rgba(0,0,0,0)","padding":0,"shadow":null,"headerFormat":"","footerFormat":"","pointFormat":"<div class=\"flexccc lineHeight2 bgwhite shadow2 px3 py3 radiismall fonth10_semibold\">\n                <span class=\"colorgray-3 mb4\">{point.date:%b %d ,%Y}</span>\n                <span>Analyst Consensus</span>\n                {point.info}\n          </div>\n           </div>"},"credits":{"enabled":false},"accessibility":{"description":""},"responsive":{"rules":[{"chartOptions":{"chart":{"spacing":[0,0,0,0],"margin":[30,60,40,5]},"xAxis":{"tickPositions":[3,12,25.25]},"yAxis":{"labels":{"enabled":false}},"title":{"text":null},"subtitle":{"text":null}},"condition":{"maxWidth":500}}]},"series":[{"lineWidth":2,"dashStyle":"ShortDash","name":"High","type":"line","color":"#199ca5","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,17.14,17.744615384615386,18.34923076923077,18.953846153846154,19.55846153846154,20.163076923076922,20.767692307692307,21.372307692307693,21.97692307692308,22.58153846153846,23.186153846153847,23.79076923076923,24.395384615384614,{"y":25,"marker":{"fillColor":"#199ca5","lineColor":"#199ca5","enabled":true,"symbol":"circle"}}]},{"lineWidth":2,"dashStyle":"ShortDash","name":"Average","type":"line","color":"#828080","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,17.14,17.683076923076925,18.226153846153846,18.76923076923077,19.31230769230769,19.855384615384615,20.39846153846154,20.94153846153846,21.484615384615385,22.027692307692305,22.57076923076923,23.113846153846154,23.65692307692308,{"y":24.2,"marker":{"fillColor":"#828080","lineColor":"#828080","enabled":true,"symbol":"circle"}}]},{"lineWidth":2,"dashStyle":"ShortDash","name":"Low","type":"line","color":"#912767","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,17.14,17.590769230769233,18.04153846153846,18.492307692307694,18.943076923076923,19.393846153846155,19.844615384615384,20.295384615384616,20.746153846153845,21.196923076923078,21.647692307692306,22.09846153846154,22.549230769230768,{"y":23,"marker":{"fillColor":"#912767","lineColor":"#912767","enabled":true,"symbol":"circle"}}]},{"type":"line","data":[{"y":20.36,"date":1733011200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 19,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 3, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":22.03,"date":1735689600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 21,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 4, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":24.04,"date":1738368000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 20,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 2, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":18.56,"date":1740787200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 17,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 5, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":19.25,"date":1743465600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 18,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 6, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":19.86,"date":1746057600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 18,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 7, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":16.35,"date":1748736000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 21,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 5, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":15.81,"date":1751328000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 19,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 4, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":13.7,"date":1754006400000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 20,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 5, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":16.36,"date":1756684800000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 17,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 4, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":18.5,"date":1759276800000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 19,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 5, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":17.06,"date":1761955200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 18,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 5, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":17.14,"date":1764547200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 15,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 5, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 1</span>\n      ","marker":{"fillColor":"black","lineColor":"black","enabled":true,"symbol":"circle"}},null,null,null,null,null,null,null,null,null,null,null,null],"color":"#0666a7"}]}

Highest Price Target$25.00

Average Price Target$24.20

Lowest Price Target$23.00

The highest, average, and lowest price target of all analysts. Click on ‘Top Analysts’ to focus on the best performers.

Detailed List of Analyst Forecasts

George Sutton

Craig-Hallum

―

Sell

―

Reiterated

12/03/25

Analysts Conflicted on These Technology Names: Cellebrite DI (NASDAQ: CLBT) and Aeva Technologies (NASDAQ: AEVA)

Jonathan Ho

William Blair

―

Buy

―

Reiterated

12/03/25

Cellebrite DI's Strategic Growth and Financial Prospects: A Buy Rating Driven by Key Acquisitions and Leadership Confidence

Eric Martinuzzi

Lake Street

$23

Buy

22.21%

Upside

Reiterated

12/02/25

Lake Street Sticks to Its Buy Rating for Cellebrite DI (CLBT)

Shaul Eyal

TD Cowen

$25

Buy

32.84%

Upside

Reiterated

11/13/25

Analysts Are Bullish on These Technology Stocks: Cisco Systems (CSCO), Cellebrite DI (CLBT)

Mike Cikos

Needham

$18→$24

Buy

27.52%

Upside

Reiterated

11/13/25

Analysts' Top Technology Picks: Cellebrite DI (CLBT), Urgent.ly Inc (ULY)

Brian Essex

J.P. Morgan

$23→$24

Buy

27.52%

Upside

Reiterated

11/13/25

Cellebrite DI (CLBT) Gets a Buy from J.P. MorganSolid 3Q Results With Multiple Levers to Accelerate in 2026; CLBT remains on our Analyst Focus List.

Tomer Zilberman

Bank of America Securities

$24→$25

Buy

32.84%

Upside

Reiterated

11/13/25

Cellebrite DI Positioned for Growth: Buy Rating Affirmed Amid Federal Demand Recovery and Strategic Alignments

Brad Zelnick

Deutsche Bank

$24→$21

Buy

11.58%

Upside

Reiterated

08/15/25

Cellebrite DI (CLBT) Gets a Buy from Deutsche Bank Deutsche Bank analyst Brad Zelnick lowered the price target on Cellebrite (NASDAQ: CLBT) to $21.00 (from $24.00) while maintaining a Buy rating.

Analyst Type

Any

Human Analysts

Ranks

Any

Analyst Rating

Any

Upside/ Downside

Any

Action

Any

George Sutton

Craig-Hallum

―

Sell

―

Reiterated

12/03/25

Analysts Conflicted on These Technology Names: Cellebrite DI (NASDAQ: CLBT) and Aeva Technologies (NASDAQ: AEVA)

Jonathan Ho

William Blair

―

Buy

―

Reiterated

12/03/25

Cellebrite DI's Strategic Growth and Financial Prospects: A Buy Rating Driven by Key Acquisitions and Leadership Confidence

Eric Martinuzzi

Lake Street

$23

Buy

22.21%

Upside

Reiterated

12/02/25

Lake Street Sticks to Its Buy Rating for Cellebrite DI (CLBT)

Shaul Eyal

TD Cowen

$25

Buy

32.84%

Upside

Reiterated

11/13/25

Analysts Are Bullish on These Technology Stocks: Cisco Systems (CSCO), Cellebrite DI (CLBT)

Mike Cikos

Needham

$18→$24

Buy

27.52%

Upside

Reiterated

11/13/25

Analysts' Top Technology Picks: Cellebrite DI (CLBT), Urgent.ly Inc (ULY)

Brian Essex

J.P. Morgan

$23→$24

Buy

27.52%

Upside

Reiterated

11/13/25

Cellebrite DI (CLBT) Gets a Buy from J.P. MorganSolid 3Q Results With Multiple Levers to Accelerate in 2026; CLBT remains on our Analyst Focus List.

Tomer Zilberman

Bank of America Securities

$24→$25

Buy

32.84%

Upside

Reiterated

11/13/25

Cellebrite DI Positioned for Growth: Buy Rating Affirmed Amid Federal Demand Recovery and Strategic Alignments

Brad Zelnick

Deutsche Bank

$24→$21

Buy

11.58%

Upside

Reiterated

08/15/25

Cellebrite DI (CLBT) Gets a Buy from Deutsche Bank Deutsche Bank analyst Brad Zelnick lowered the price target on Cellebrite (NASDAQ: CLBT) to $21.00 (from $24.00) while maintaining a Buy rating.

Stocks with the Highest Top Analyst Consensus in the Technology Sector

xxx

Find stocks in the Technology sector that are highly recommended by Top Performing Analysts.

Best Analysts Covering Cellebrite DI

1 Month

xxx

Success Rate

9/14 ratings generated profit

Average Return

+2.67%

reiterated a xxx

rating 13 days ago

Copying xxxxxxxxxxxxxxxxxx

trades and holding each position for 1 Month would result in 64.29% of your transactions generating a profit, with an average return of +2.67% per trade.

3 Months

xxx

Success Rate

9/14 ratings generated profit

Average Return

+13.94%

reiterated a xxx

rating 13 days ago

Copying xxxxxxxxxxxxxxxxxx

trades and holding each position for 3 Months would result in 64.29% of your transactions generating a profit, with an average return of +13.94% per trade.

1 Year

Eric MartinuzziLake Street

Success Rate

10/14 ratings generated profit

Average Return

+13.33%

reiterated a buy rating 13 days ago

Copying Eric Martinuzzi's trades and holding each position for 1 Year would result in 71.43% of your transactions generating a profit, with an average return of +13.33% per trade.

2 Years

xxx

Success Rate

22/30 ratings generated profit

Average Return

+64.80%

reiterated a xxx

rating last month

Copying xxxxxxxxxxxxxxxxxx

trades and holding each position for 2 Years would result in 73.33% of your transactions generating a profit, with an average return of +64.80% per trade.

The Best Analyst Covering tool allows you to follow the analysts who have the best success rates and average returns on a specific stock. Only analysts that gave a Buy or Sell rating on the stock in the past 12 months are eligible for inclusion in this tool. Follow the analysts of your choice to receive real-time updates when they publish a new rating.

CLBT Analyst Recommendation Trends

Rating

Aug 25

Sep 25

Oct 25

Nov 25

Dec 25

Strong Buy

Buy

Hold

Sell

Strong Sell

total

In the current month, CLBT has received 15 Buy Ratings, 5 Hold Ratings, and 1 Sell Ratings. CLBT average Analyst price target in the past 3 months is 24.20.

Each month's total comprises the sum of three months' worth of ratings.

CLBT Financial Forecast

CLBT Earnings Forecast

Next quarter’s earnings estimate for CLBT is $0.10 with a range of $0.08 to $0.15. The previous quarter’s EPS was $0.08. CLBT beat its EPS estimate ― of the time in the past 12 months, while its overall industry beat the EPS estimate 67.75% of the time in the same period. In the last calendar year CLBT has Performed in-line its overall industry.

CLBT Sales Forecast

Next quarter’s sales forecast for CLBT is $126.07M with a range of $123.17M to $128.00M. The previous quarter’s sales results were $126.03M. CLBT beat its sales estimates ― of the time in past 12 months, while its overall industry beat sales estimates 71.26% of the time in the same period. In the last calendar year CLBT has Performed in-line its overall industry.

CLBT Stock Forecast FAQ

What is CLBT’s average 12-month price target, according to analysts?

Based on analyst ratings, Cellebrite DI’s 12-month average price target is 24.20.

What is CLBT’s upside potential, based on the analysts’ average price target?

Cellebrite DI has 28.59% upside potential, based on the analysts’ average price target.

Can I see which stocks the top-ranking analysts are rating?

Yes, go to the Analysts’ Top Stocks tool to see stocks with a Strong Buy or Strong Sell analyst rating consensus, according to the top performers.

How can I follow the stock ratings of top Wall Street analysts?

Head over to our Expert Center to see a list of the top 100 Wall Street analysts and follow the analysts of your choice. Visit their profiles for more details about their stock ratings and see how they perform on a stock-by-stock basis.

Is CLBT a Buy, Sell or Hold?

Cellebrite DI has a consensus rating of Moderate Buy which is based on 6 buy ratings, 0 hold ratings and 1 sell ratings.

What is Cellebrite DI’s price target?

The average price target for Cellebrite DI is 24.20. This is based on 7 Wall Streets Analysts 12-month price targets, issued in the past 3 months.
The highest analyst price target is $25.00 ,the lowest forecast is $23.00. The average price target represents 28.59% Increase from the current price of $18.82.

What do analysts say about Cellebrite DI?

Cellebrite DI’s analyst rating consensus is a Moderate Buy. This is based on the ratings of 7 Wall Streets Analysts.

How can I buy shares of CLBT?

Open a brokerage account, see exclusive account opening deals on our Best Online Brokers page.

Cellebrite DI (CLBT) Stock Forecast & Price Target

CLBT Analyst Ratings

CLBT Stock 12 Month Forecast

Average Price Target

Detailed List of Analyst Forecasts​

Best Analysts Covering Cellebrite DI

CLBT Analyst Recommendation Trends

CLBT Financial Forecast

CLBT Earnings Forecast

CLBT Sales Forecast

CLBT Stock Forecast FAQ

Detailed List of Analyst Forecasts